Recherche
-
Oral Morphine as an Alternative Substitution Treatment for Opioid Use Disorder, a Rare but Non-risk-free Use
(Frontiers in Psychiatry. vol. 13, 2022-06-30)Article de revueLibre accès -
Real-world effect of iloprost in patients with chronic limb-threatening ischemia (CLTI): A cohort study
(Vascular Medicine. pp. 1358863X231209263, 2023-11-07)Article de revue -
Systematic review on sex differences for drug use after stroke
(Therapies. vol. 78, pp. 213-224, 2023-03)Article de revue -
Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390
(Diabetes Care. vol. 46, n° 5, pp. e121-e122, 2023-05-01)Article de revue -
GLP-1 Receptor Agonists and the Risk of Thyroid Cancer
(Diabetes Care, 2022-11-10)Article de revue -
Targeting of under-75 years for the optimization of medication reconciliation with an approach based on medication risks: An observational study
(Thérapie, 2021-06-18)Article de revue -
Trends in use of benzodiazepines and Z-drugs in France from 2012 to 2020
(Therapies, 2022-12-09)Article de revue -
High prevalence of spin was found in pharmacovigilance studies usingdisproportionality analyses todetectsafetysignals: a meta-epidemiologicalstudy: Spin in pharmacovigilance disproportionality analyses
(Journal of Clinical Epidemiology. vol. 138, pp. 73-79, 2021-06-26)Article de revue -
Will the future of pharmacovigilance be more automated?
(Expert Opinion on Drug Safety. vol. 22, n° 7, pp. 541-548, 2023-07-01)Article de revue -
Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy
(Thérapie, 2021-04-02)Article de revue